Wells Fargo’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.01K | Sell |
6,826
-38,894
| -85% | -$28.5K | ﹤0.01% | 5628 |
|
|
2025
Q1 | $45.7K | Sell |
45,720
-24,933
| -35% | -$24.9K | ﹤0.01% | 4982 |
|
|
2024
Q4 | $749K | Buy |
70,653
+13,196
| +23% | +$140K | ﹤0.01% | 3456 |
|
|
2024
Q3 | $759K | Sell |
57,457
-1,023
| -2% | -$13.5K | ﹤0.01% | 3372 |
|
|
2024
Q2 | $575K | Buy |
58,480
+23,537
| +67% | +$231K | ﹤0.01% | 3492 |
|
|
2024
Q1 | $480K | Buy |
34,943
+7,588
| +28% | +$104K | ﹤0.01% | 3577 |
|
|
2023
Q4 | $466K | Buy |
+27,355
| New | +$466K | ﹤0.01% | 3567 |
|